New research is now beginning to shine a spotlight on CBD as a potential alternative to anti-psychotic medication. “A Critical Review of the Anti-Psychotic Effects of Cannabidiol: 30 Years of a Translational Investigation,” published by Bentham Science Publishers in 2012, gives a detailed look into 24 complimentary studies that tested CBD as an anti-psychotic medication in animal and human patients. The outcome of the review led researchers to conclude that “the results discussed above clearly indicate that CBD behaves in preclinical and clinical studies as an atypical anti-psychotic, improving psychotic-like symptoms in doses that do not impair motor function” and that “these results support the idea that CBD may be a future therapeutic option in psychosis, in general and in schizophrenia, in particular.”
Research like this is very motivating news for patients who still have only a few options when trying to find relief from their disorder, especially considering that CBD have shown repeatedly to have no proven side effects, other than fatigue in extreme cases. Although a general consensus has not yet been reached on whether or not CBD have a future a front line option for patients suffering from a form of psychosis, the new attention reviews like this will give to CBD will hopefully spur new research into this potentially life altering medication.